1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Annual direct medical cost of active systemic lupus erythematosus in five European countries
(
- Contribution to journal › Article
- 2012
-
Mark
Economic studies in rheumatology: data, perspectives, challenges.
(
- Contribution to journal › Article
- 2010
-
Mark
Cost of Illness from the Public Payers' Perspective in Patients with Ankylosing Spondylitis in Rheumatological Care.
(
- Contribution to journal › Article
- 2009
-
Mark
Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data
(
- Contribution to journal › Article
- 2008
-
Mark
The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data.
(
- Contribution to journal › Article
- 2007
-
Mark
Costs of rheumatoid arthritis in Hungary
(
- Contribution to journal › Letter
- 2006
-
Mark
Health economic issues in rheumatoid arthritis
(
- Contribution to journal › Scientific review